Back to the list
Congress: ECR25
Poster Number: C-12663
Type: Poster: EPOS Radiologist (scientific)
DOI: 10.26044/ecr2025/C-12663
Authorblock: M. D. C. Rodríguez Calvo1, M. I. Martínez León2, L. M. M. Kubandt2, M. A. Pérez Benítez3, I. Hidalgo Hurtado4, C. Madrid Lopez5, C. Osuna Otal5, L. Muñoz Olmo6; 1El Puerto de Santa María/ES, 2MALAGA/ES, 3Conil de la Frontera/ES, 4Jerez de la Frotnera/ES, 5Cadiz/ES, 6San Fernando/ES
Disclosures:
María Del Camino Rodríguez Calvo: Nothing to disclose
María Isabel Martínez León: Nothing to disclose
Leona María Manzano Kubandt: Nothing to disclose
Manuel Alejandro Pérez Benítez: Nothing to disclose
Ildefonso Hidalgo Hurtado: Nothing to disclose
Cesar Madrid Lopez: Nothing to disclose
Cristina Osuna Otal: Nothing to disclose
Luis Muñoz Olmo: Nothing to disclose
Keywords: Musculoskeletal system, Neuroradiology peripheral nerve, Paediatric, CT, MR, Complications, Image compression, Radiation therapy / Oncology, Cancer, Metastases, Neoplasia
Conclusion
  • NF1 predisposes individuals to the development of neoplasms such as PNF.
  • European guidelines recommend whole-body MRI in asymptomatic patients during early adolescence to detect and monitor tumor growth, reduce morbidity, and identify malignant transformation.
  • PNF causes aesthetic and musculoskeletal alterations, with scoliosis being the most common.
  • MPNSTs are the leading cause of death in NF1 patients, making early detection and management crucial.
  • New medical therapies, such as Selumetinib, have proven effective and present fewer complications compared to surgery.
GALLERY